AbbVie Newsroom

Redburn Atlantic Adjusts AbbVie's Price Target to $216 From $215, Keeps Buy Rating

MT NewswiresNov 16 01:44

Wolfe Research Initiates AbbVie(ABBV.US) With Buy Rating, Announces Target Price $205

Futu NewsNov 15 05:31

AbbVie Analyst Ratings

BenzingaNov 13 22:57

J.P. Morgan Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $200

Futu NewsNov 13 20:32

JPMorgan Adjusts Price Target on AbbVie to $200 From $210, Keeps Overweight Rating

MT NewswiresNov 13 20:08

UBS downgraded AbbVie's target price to $224.

Gelonghui FinanceNov 13 16:10

AbbVie Hold Rating Maintained Amid Emraclidine Trial Challenges and Competitive Pressure

TipRanksNov 13 15:11

UBS Maintains AbbVie(ABBV.US) With Hold Rating, Cuts Target Price to $181

Futu NewsNov 13 03:32

AbbVie Is Maintained at Buy by Citigroup

Dow JonesNov 13 03:08

BMO Capital Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $208

Futu NewsNov 12 22:35

AbbVie Is Maintained at Overweight by Morgan Stanley

Dow JonesNov 12 21:39

AbbVie Analyst Ratings

BenzingaNov 12 21:31

Morgan Stanley Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $224

Futu NewsNov 12 19:35

Citi Maintains AbbVie(ABBV.US) With Buy Rating, Cuts Target Price to $215

Futu NewsNov 12 19:35

AbbVie Buy Rating Affirmed Despite Emraclidine Setback, Driven by Skyrizi and Rinvoq Growth

TipRanksNov 12 19:13

Positive Outlook on AbbVie: Geoff Meacham's Buy Rating and Potential of Emraclidine Amid Schizophrenia Trial Challenges

TipRanksNov 12 19:12

BMO Capital Adjusts Price Target on AbbVie to $208 From $228, Maintains Outperform Rating

MT NewswiresNov 12 18:46

Citigroup Adjusts AbbVie Price Target to $215 From $226

MT NewswiresNov 11 23:51

Barclays Maintains AbbVie(ABBV.US) With Buy Rating, Maintains Target Price $212

Futu NewsNov 11 23:33

Positive Long-Term Growth Outlook for AbbVie Despite Emraclidine Setback: Analyst Maintains Buy Rating

TipRanksNov 11 23:19